Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different Doses of IVIG for Kawasaki Disease
NCT02439996Phase 3Completed
- Sponsor
- Children's Hospital of Fudan University
- Start
- Jan 2014
- Primary completion
- Mar 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of intravenous immunoglobulin G in Kawasaki disease (KD), sponsored by Children's Hospital of Fudan University. Started Jan 2014; status: completed.
02
Drugs
intravenous immunoglobulin G
03
Conditions
Kawasaki disease (KD)
Beyond the preview
Go deeper on NCT02439996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02439996.